Skip to main content
Premium Trial:

Request an Annual Quote

People In The News: Aug 14, 2009

NEW YORK (GenomeWeb News) - Millipore has named John Sweeney to be VP of its Life Science business unit. Sweeney recently was VP of Strategy and Marketing services for Millipore's Bioscience Division, and he joined the company in 2003 as director of strategy and corporate development.

Leroy Hood and George Church have joined Cellular Dynamics' scientific advisory board. Hood is co-founder of the Institute for Systems Biology and is known as a DNA sequencing pioneer. He also was a co-founder of Amgen and Applied Biosystems.

Church is a professor of genetics at Harvard Medical School. He also is director of the Lipper Center for Computational Genetics, DOE Genomes to Life Center, NIH Center for Excellence in Genomics Science, and the Personal Genome Project.

The Genetics and Public Policy Center at Johns Hopkins University said this week that Susannah Baruch and Sara Katsanis have left the center to pursue new opportunities.

Baruch, who has been a law and policy director at the center since 2003, will be directing the Washington, DC, policy work for Generations Ahead. Katsanis, who has worked as a research analyst at the center since 2007, will join Duke University's Institute for Genome Sciences and Policy as an associate in research focused on genetic testing in medicine and law enforcement.

DxS has appointed Dave Clennell to be the company's director of quality. Clennell has worked in healthcare quality for 30 years, DxS said, and he has been international director of quality for Lombard Medical Technologies. He also has held senior roles at Johnson & Johnson, Genzyme, and SmithKline Beecham Pharmaceuticals.

BioTek Instruments has named Danny Luo to be General Manager of the company's China office. Luo has been the company's marketing manager for China and Hong Kong since 2006.

Many of Nanogen's executives resigned from the firm this week, a month after the firm sold its assets to Elitech for $25.7 million. The resignations were authorized by the United States Bankruptcy Court for the District of Delaware.

The resignations included Chairman Howard Birndorf, who resigned as CEO last month, and board members David Schreiber, Robert Whalen, Stelio Papadopoulos, and Heiner Dreismann.

In addition, Graham Lidgard resigned as SVP of R&D, while David Ludvigson, who served as the president and COO of the company prior to the issuance of the court's order, was appointed to serve as the president and secretary of Nanogen. Nicholas Venuto, who served as CFO of the firm prior to the order, was re-appointed CFO, according to the firm's SEC filing.

Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People in the News, a weekly roundup of industry comings and goings.

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.